(Q45370699)

13 December 2017

title

Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells (English)

1 reference

13 December 2017

1 reference

1 reference

Zixue Jin

1

1 reference

13 December 2017

Rui Sun

2

1 reference

13 December 2017

Haiming Wei

3

1 reference

13 December 2017

Xiang Gao

4

1 reference

13 December 2017

Yongyan Chen

5

1 reference

13 December 2017

Zhigang Tian

6

1 reference

13 December 2017

language of work or name

English

0 references

publication date

7 December 2010

1 reference

13 December 2017

1 reference

13 December 2017

volume

53

1 reference

13 December 2017

issue

1

1 reference

13 December 2017

page(s)

219-229

1 reference

13 December 2017

1 reference

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

21 January 2018

1 reference

Structure and function of hepatic stellate cells

21 January 2018

1 reference

Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.

21 January 2018

1 reference

Liver fibrosis: searching for cell model answers

21 January 2018

1 reference

Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications

21 January 2018

1 reference

Global challenges in liver disease

21 January 2018

1 reference

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

21 January 2018

1 reference

Liver fibrosis and chronic viral hepatitis.

21 January 2018

1 reference

Polymorphisms of glutathione S-transferase M1, T1, and P1 in patients with HBV-related liver cirrhosis, chronic hepatitis, and normal carriers.

21 January 2018

1 reference

Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells

21 January 2018

1 reference

Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes

21 January 2018

1 reference

Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes

21 January 2018

1 reference

Attenuated liver fibrosis in the absence of B cells

21 January 2018

1 reference

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

21 January 2018

1 reference

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

21 January 2018

1 reference

Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride

21 January 2018

1 reference

Harnessing invariant NKT cells in vaccination strategies

21 January 2018

1 reference

Fibrotic disease and the T(H)1/T(H)2 paradigm

21 January 2018

1 reference

Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution.

21 January 2018

1 reference

Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis

21 January 2018

1 reference

A transgenic mouse model of the chronic hepatitis B surface antigen carrier state

21 January 2018

1 reference

NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis

21 January 2018

1 reference

Ito cells are liver-resident antigen-presenting cells for activating T cell responses

21 January 2018

1 reference

Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.

21 January 2018

1 reference

Experimental models of hepatic fibrosis: a review

21 January 2018

1 reference

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

21 January 2018

1 reference

Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes

21 January 2018

1 reference

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

Cytokine-induced viral purging--role in viral pathogenesis.

21 January 2018

1 reference

Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells

21 January 2018

1 reference

Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus

21 January 2018

1 reference

Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.

21 January 2018

1 reference

CD1-restricted T cell recognition of microbial lipoglycan antigens

21 January 2018

1 reference

21 January 2018

1 reference

NK and NKT cells in liver injury and fibrosis

21 January 2018

1 reference

NKT cells: what's in a name?

21 January 2018

1 reference

A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

21 January 2018

1 reference

Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.23983

1 reference

13 December 2017

1 reference